On TRACk, a blended intervention that prepares both patients and pharmacy technicians for two inhaler medication consultations and trains technicians in their communication will improve inhaler medication adherence and inhaler technique in patients…
ID
Bron
Verkorte titel
Aandoening
Asthma/COPD
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
adherence to inhaler medication and inhaler technique
Achtergrond van het onderzoek
RESEARCH QUESTION: Can on TRACk, a TRain, prepAre, Communicate strategy, improve inhaler medication adherence and inhaler technique of lung patients?
INTERVENTION: On TRACk combines two innovative and proven successful elements: (1) online training of PTs to improve their inhaler medication counseling (both content, including giving a correct inhalation instruction, and patient-centred communication style), (2) preparing technicians and patients for these counseling moments in which inhaler technique is evaluated and medication use is discussed based on topics chosen by patients.
Doel van het onderzoek
On TRACk, a blended intervention that prepares both patients and pharmacy technicians for two inhaler medication consultations and trains technicians in their communication will improve inhaler medication adherence and inhaler technique in patients with asthma/COPD and lead to better health outcomes
Onderzoeksopzet
participants fill out questionnaires are t=0, with follow up every three months for a year. Participants in the intervention group will have planned dispence conversations at t=3 and t=9.
Onderzoeksproduct en/of interventie
In step 1, PTs will be trained with the On TRACk training. Hereto they will videotape five planned second dispense conversations and upload these through a secure connection via their personal account to the On TRACk web portal following strict protocols. Two conversations will be selected by the trainer to perform self-reflection and provide personal feedback, both online.
In step 2, trained PTs invite eligible patients who collect inhaler medication for the first time to participate in the study. For patients, participation involves preparing themselves for a planned second dispense conversation in the pharmacy using materials provided via the On TRACk web portal. Patients hereto are given access with personal log in data to the web portal. Here they will find information about the medication and their illness, and tips and tools to support their self-management. They will select topics for the conversation using a question prompt list (QPL). A QPL is a structured list with questions designed to aid patients’ question asking behavior. This information will be send via the portal to the PT so that (s)he can prepare the conversation using the topics selected by the patient.
In step 3, the planned second dispense conversation takes place in the pharmacy consultation room in which all topics are discussed, as well as demonstration and refinement of the inhaler technique. A follow-up conversation will be planned at six months to monitor inhaler technique (including suitability of the device) and medication use.
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
All patients with asthma and/or COPD who collect their maintenance inhaler medication for the first time in the community pharmacy will be asked consecutively to participate in this study by the pharmacy technician. Further inclusion criteria are: (1) aged 16 years or older, (2) understanding the Dutch language.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
(1) simultaneous experimental SABA use, (2) cognitive impairment.
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Toelichting
What data in particular will be shared? Individual participant data that underlie the results reported in the upcoming articles that will be written based on the trial outcomes, after deidentification. I.E. text, tables figures and appendices.
What other documents will be available? Study protocol, peer reviewed articles with results from the trial (ultimately bundled in a PhD thesis)
When will data be available (start and end dates)? Directly after publishing clinical study reports. Maximum of three years.
With whom? At request, for researchers who will provide a methodologically sound proposal.
For what types of analyses? To achieve the aims in the approved proposal.
By what mechanism will data be made available? Proposals should be directed to R.tePaske@nivel.nl, M.Vervloet@nivel.nl or L.vandijk@nivel.nl. To gain access, data requestors will need to sign a data access agreement. Data are available for 3 years at third party website.
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL9750 |
Ander register | METc VUmc : 2020.358 |